Search for company
Explore more than 1.3 million company profiles from emerging markets

INCD Cantacuzino (Romania)

Main Activities: Research and Development in Biotechnology
Select Items to chart them. 2014 H1
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
Net Profit(Loss)
Total Assets 282,006
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Individual
Source: Creditinfo Romania, EMIS Company Database.
Company Description

National Institute of Research and Development for Microbiology and Immunology "Cantacuzino" (INCDMI "Cantacuzino") is a research institute in Romania, founded in 1921. Institute's field of activity is public health, which promotes both the research development and by offering products and services. Scientific research, technological development and innovation are conducted in the areas of bacterial, viral and parasitic cellular and molecular biology, immunology, biotechnology and microbial…

Main Products

Research in the field of microbiology, epidemiology, immunology, cell biology, microbial genetics and biotechnology. Cooperate and exchange information permanently out scientific and technical research and educational institutes of high prestige in the world.

Contact Information

104, Splaiul Independentei Sector 5
Bucharest; Bucharest; Map
Postal Code: 050096
Tel: +40 213 069 125, +40 213 069 200
Fax: +40 213 069 307

Full name: Institutul National De Cercetare Dezvoltare Pentru Microbiologie Si Imunologie Cantacuzino

Status: Non-Listed
Legal Form: Other non-liability limited
Operational Status: Operational
CUI: 15203810
Incorporation Date: 1921

Basic Information
Total Employees:
Registered Capital:
Key Executives
General Manager
Ownership Details
Ministry of Education
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Competitors - Romania

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.